stromal tumor Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (2)

Phase 1 (1)
Phase 1/2 (1)

Interventional (2)

CStone Pharmaceuticals (1)
Daiichi Sankyo, Inc. (1)

No (2)

No (2)

Adult (18+) (2)

I am/have/had

I am/have/hadpdgfra d842v

I am/have/hadliver metastasis

I am/have/hadplatelet count

I am/have/hadmeasurable disease

I am/have/hadmajor surgery

I am/have/hadejection fraction

I am/have/hadneutrophil count

I am/have/hadcancer treatment

I am/have/hadtyrosine

I am/have/hadimmunohistochemistry

I am/have/hadminor surgery

I am/have/hadmetastasis

I am/have/hadstromal tumor

I am/have/hadgastrointestinal stromal tumor

I am/have/hadcancer

I am/have/hadgilbert's syndrome

I am/have/hadpdgfra gene

I am/have/hadpdgfra d842v mutation

added new label for I am/have/had

more

I am looking for

I am looking forimatinib

I am looking fortyrosine

I am looking forkinase inhibitor

I am looking forgrowth factor

I am looking forchemotherapeutic agent

I am looking foradjuvant

I am looking forblu-285

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

A Study of CS3007 in Subjects With Gastrointestinal Stromal Tumor

This study is an open-label, multicenter, phase I/II study to evaluate the safety, PK and clinical efficacy of avapritinib in Chinese subjects with unresectable or metastatic GIST. The study consists of two parts: dose escalation (phase I) and dose expansion (phase II).

tyrosine

kinase inhibitor

blu-285

imatinib

stromal tumor

0 views
16 Feb, 2024
1 location

Multi-country trial
Phase 1
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Recruiting

DS-6157a in Participants With Advanced Gastrointestinal Stromal Tumor (GIST)

This study will assess the safety, efficacy, and pharmacokinetics of DS-6157a in participants with advanced gastrointestinal stromal tumors (GIST).

pdgfra d842v

liver metastasis

chemotherapeutic agent

imatinib

platelet count

0 views
16 Feb, 2024
2 locations

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.